Allan F. Moore Memorial Endocrine Lecture
Tuesday, February 26, 2019
Ether Dome, Bulfinch 4
“Genetic Variation and the Epigenomic Modulation of Metabolism”
Presented by Mitchell A. Lazar, M.D., PhD
Upon completion of this activity, participants will be able to:
- Understand the mechanism of a class of anti-diabetic drugs
- Understand how natural genetic variation can influence individual responses to drugs
- Learn an example of predicting adverse drug effects from individual genetic variation
Target Audience: The target audience for this activity is Endocrinologists and Health Care Professionals with an interest in Endocrine Topics
Course Director: Henry Kronenberg, M.D./Jose Florez, M.D., Ph.D.
Partners HealthCare System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Partners HealthCare System designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.